Sign In
Buy ALKS
$42.76
+1.44 (+3.48%)
At Close: Jun 03, 2026
Alkermes price target lowered to $23 from $25 at H.C. Wainwright ALKS
11:34am, Thursday, 30'th Apr 2020
Alkermes price target lowered to $23 from $25 at H.C. Wainwright H.C. Wainwright ALKS
HC Wainwright & Co. Reiterates Neutral on Alkermes, Lowers Price Target to $23
11:23am, Thursday, 30'th Apr 2020Wall Street Analysts Are Neutral on Top Healthcare Picks
11:21am, Thursday, 30'th Apr 2020
Analysts fell to the sidelines weighing in on Vertex Pharmaceuticals (VRTX), United Therapeutics (UTHR) and Alkermes (ALKS) with neutral ratings,
108 Biggest Movers From Yesterday
09:30am, Thursday, 30'th Apr 2020
Gainers
Capricor Therapeutics, Inc. (NASDAQ: CAPR) shares jumped 252.7% to close at $8.50 on Wednesday after the company reported that its new data from study of 6 critically-ill...
Alkermes (NASDAQ:ALKS) Trading Down 10.6% After Analyst Downgrade
06:18am, Thursday, 30'th Apr 2020
Alkermes Plc (NASDAQ:ALKS)’s stock price was down 10.6% during mid-day trading on Wednesday after Piper Sandler lowered their price target on the stock from $22.00 to $21.00. Piper Sandler currently
Alkermes' (ALKS) Q1 Earnings Increase Y/Y, Revenues Beat
12:00am, Thursday, 30'th Apr 2020Edited Transcript of ALKS earnings conference call or presentation 29-Apr-20 12:00pm GMT
09:56pm, Wednesday, 29'th Apr 2020
Q1 2020 Alkermes Plc Earnings Call
Alkermes PLC (ALKS) Q1 2020 Earnings Call Transcript
07:00pm, Wednesday, 29'th Apr 2020
ALKS earnings call for the period ending March 31, 2020.
Alkermes PLC shares are trading lower after the company reported Q1 earnings results.
05:32pm, Wednesday, 29'th Apr 2020Alkermes Q1 EPS $0.010 Beats $(0.060) Estimate, Sales $246.220M Beat $228.230M Estimate
05:31pm, Wednesday, 29'th Apr 2020Alkermes plc's (ALKS) CEO Richard Pops on Q1 2020 Results - Earnings Call Transcript
04:53pm, Wednesday, 29'th Apr 2020
Alkermes plc (NASDAQ:ALKS) Q1 2020 Results Earnings Conference Call April 29, 2020, 08:00 AM ET Company Participants Sandra Coombs - Vice President, Investor Re
Alkermes price target lowered to $17 from $20 at Stifel ALKS
04:47pm, Wednesday, 29'th Apr 2020
Alkermes price target lowered to $17 from $20 at Stifel Stifel ALKS
Alkermes price target lowered to $21 from $22 at Piper Sandler ALKS
04:47pm, Wednesday, 29'th Apr 2020
Alkermes price target lowered to $21 from $22 at Piper Sandler Piper Sandler ALKS
The Daily Biotech Pulse: Inovio's MERS Vaccine Data, Fast Track Designation For Erytech, FDA Approves Higher Dose Of Merck's Keytruda
12:40pm, Wednesday, 29'th Apr 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit 52-week highs April 28.) * AstraZeneca plc (NYSE: AZN) * Arcturus Therapeu
Mizuho Securities Maintains Their Hold Rating on Alkermes (ALKS)
11:55am, Wednesday, 29'th Apr 2020
In a report released today, Vamil Divan from Mizuho Securities maintained a Hold rating on Alkermes (ALKS), with a price target of $16.00. The company's
